Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Korosho to Strictly Crack Down on Suspicious Health Foods
August 5, 2002
- REGULATORY NEWS IN BRIEF
July 29, 2002
- 15th Interphex Japan
July 29, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 29, 2002
- Nippon Chemiphar to Beef Up Its Generic Business
July 29, 2002
- Asahi Kasei to Look For Lead Compounds with SGX
July 29, 2002
- Promoting GE Use Needs Various Means: Mr Wright of EFPIA
July 29, 2002
- MPC-backed New Foundation Invites Applications for CV Research Grants
July 29, 2002
- Takeda to Expand Lineup of Antidiabetic Drugs
July 29, 2002
- GL on Subarachnoidal Hemorrhages Prepared by Korosho Study Group
July 29, 2002
- Bayer Wants to Keep 2-3% Increase in Adalat Sales
July 29, 2002
- Public Health Research Center Initiates Clinical Study on Breast Cancer
July 29, 2002
- Kuraya Sanseido Aims at Operating Profit Ratio of 2%
July 29, 2002
- Press Seminar
July 29, 2002
- Fukujin Agrees on Prices with Only 20% of Hospitals by End of June
July 29, 2002
- Takara Bio to Develop New Gene Detection System with Nanosphere
July 29, 2002
- Taiyo Pharm Beefs Up Contract Manufacturing Business
July 29, 2002
- Roche Diagnostics: Simple Blood Glucose Determination System, Accu-Chek Active
July 29, 2002
- BUSINESS NEWS IN BRIEF
July 29, 2002
- Eiken, Sysmex Tie Up to Market Urinarysis System in China
July 29, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…